Category: MedtronicSyndicate content

Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014

October 30, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Medtronic updates on $43B Covidien deal financing; Boston Scientific, Bard CEOs cool on consolidation; Nevro sets range for IPO of up to $106m; Alere to sell Alere Health unit to Optum for $600m; Skyline Medical conducts 1-for-75 reverse stock split

Medtronic updates on $43B Covidien deal financing

October 24, 2014 by Brad Perriello

Medtronic, Covidien merger expected to close in 2015

October 30, 2014 by Brad Perriello

Medtronic and Covidien say their pending, $43 billion merger is expected to close in early 2015.

Medtronic, Covidien merger expected to close in 2015

COV will likely divest some vascular therapies ahead of MDT merger | The week in medtech M&A

October 29, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Covidien plans to sell some vascular therapies ahead of Medtronic merger; Covidien, Medtronic shares jump on affirmation of $43B merger; Wright Medical to acquire Tornier for $3.3B in inversion deal; Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic; Globus Medical snaps up allograft maker Transplant Technologies

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Medtronic launches surgical aortic valve trial

October 28, 2014 by Brad Perriello

Medtronic launches a clinical trial to study a new replacement heart valve designed to be surgically implanted in patients with severe aortic stenosis.

Medtronic launches surgical aortic valve trial

Medtronic (NYSE:MDT) today said it launched a clinical trial for a new replacement heart valve designed for patients with severe narrowing of the aortic valve.

Former BSX engineer indicted on charges of stealing balloon cath trade secrets from the company | Medtech legal news for the week of October 27, 2014

October 27, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Ex-Boston Scientific engineer accused of stealing balloon catheter secrets; Jury clears DePuy in 1st Pinnacle bellwether trial; U.S. Patent Office denies Medtronic request in Endotach stent case; Jury deliberations begin in first trial over DePuy's Pinnacle hips; Johnson & Johnson's DePuy wins first trial over Pinnacle hips

Ex-Boston Scientific engineer accused of stealing balloon catheter secrets

October 21, 2014 by Brad Perriello

Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic

October 27, 2014 by Brad Perriello

Integra LifeSciences says it closed the $60 million buy of a pair of Medtronic's ear, nose & throat instrument lines.

Integra LifeSciences closes MicroFrance, Xomed buy from Medtronic

Covidien plans to sell some vascular therapies ahead of Medtronic merger

October 24, 2014 by Brad Perriello

Covidien says it plans to divest its some of its vascular therapies business to mollify U.S. anti-trust regulators about its proposed $43 billion merger with Medtronic.

Covidien plans to sell some vascular therapies ahead of Medtronic merger
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp